Acute kidney injury in the critically ill: an updated review on pathophysiology and management

P Pickkers, M Darmon, E Hoste, M Joannidis… - Intensive care …, 2021 - Springer
Acute kidney injury (AKI) is now recognized as a heterogeneous syndrome that not only
affects acute morbidity and mortality, but also a patient's long-term prognosis. In this …

Clinical practice guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing: a consensus review by the Japanese …

K Matsumoto, K Oda, K Shoji, Y Hanai, Y Takahashi… - Pharmaceutics, 2022 - mdpi.com
Background: To promote model-informed precision dosing (MIPD) for vancomycin (VCM),
we developed statements for therapeutic drug monitoring (TDM). Methods: Ten clinical …

[HTML][HTML] Clinical practice guideline for the therapeutic drug monitoring of voriconazole in non-Asian and Asian adult patients: consensus review by the Japanese …

Y Takesue, Y Hanai, K Oda, Y Hamada, T Ueda… - Clinical Therapeutics, 2022 - Elsevier
Purpose Voriconazole, an antifungal drug, is metabolized by a cytochrome P450 isozyme.
Increased adverse effects are observed in Asians because of the high rate of poor …

Validation of vancomycin area under the concentration—Time curve estimation by the Bayesian approach using one-point samples for predicting clinical outcomes in …

T Ueda, Y Takesue, K Nakajima, K Ichiki, K Ishikawa… - Antibiotics, 2022 - mdpi.com
Area under the concentration–time curve (AUC)-guided vancomycin treatment is associated
with decreased nephrotoxicity. It is preferable to obtain two samples to estimate the AUC …

Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of …

Y Hanai, Y Takahashi, T Niwa, T Mayumi… - Journal of …, 2022 - academic.oup.com
Background Owing to its low risk of adverse effects, teicoplanin has been extensively used
in patients with infections caused by MRSA. To promote the better management of patients …

Optimal practice for vancomycin therapeutic drug monitoring: position statement from the anti-infectives committee of the international association of therapeutic drug …

SE Reuter, SL Stocker, JWC Alffenaar… - Therapeutic Drug …, 2022 - journals.lww.com
Individualization of vancomycin dosing based on therapeutic drug monitoring (TDM) data is
known to improve patient outcomes compared with fixed or empirical dosing strategies …

Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory …

M Samura, Y Kitahiro, S Tashiro, H Moriyama… - Pharmaceutics, 2022 - mdpi.com
This systematic review and meta-analysis compares the efficacy of daptomycin and
vancomycin in adult patients with bacteremia by methicillin-resistant Staphylococcus aureus …

[HTML][HTML] An update on treatment options for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: a systematic review

F Mahjabeen, U Saha, MN Mostafa, F Siddique… - Cureus, 2022 - ncbi.nlm.nih.gov
Since the last century, methicillin-resistant Staphylococcus aureus (MRSA) bacteremia has
become a major global and public health concern not only in terms of morbidity and mortality …

Comparison of Bayesian‐derived and first‐order analytic equations for calculation of vancomycin area under the curve

KB Olney, KL Wallace, RP Mynatt… - … : The Journal of …, 2022 - Wiley Online Library
Introduction Consensus guidelines recommend targeting a vancomycin area under the
curve to minimum inhibitory concentration (AUC24: MIC) ratio of 400–600 to improve …

Time-dependent differences in vancomycin sensitivity of macrophages underlie vancomycin-induced acute kidney injury

Y Yoshida, T Fukuda, K Fukuoka, T Nagayama… - … of Pharmacology and …, 2024 - ASPET
Although vancomycin (VCM)—frequently used to treat drug-resistant bacterial infections—
often induces acute kidney injury (AKI), discontinuation of the drug is the only effective …